Eurofins Scientific SE/ FR0014000MR3 /
| 3/31/2023 5:29:38 PM | Chg. -0.96 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 61.62EUR | -1.53% | 224,380 Turnover: 7.16 mill. |
-Bid Size: - | -Ask Size: - | 12.57 bill.EUR | 1.10% | 21.26 |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.90 EUR | 164.36% |
| EPS Diluted: | 2.75 EUR | 162.66% |
| Revenues per Share: | 29.21 EUR | 127.90% |
| Book Value per Share: | 19.82 EUR | 148.56% |
| Cash Flow per Share: | 6.57 EUR | 245.07% |
| Dividend per Share: | 0.68 EUR | - |
| Total | in mill. | |
| Revenues: | 5,438.80 EUR | 19.20% |
| Net Income: | 540.50 EUR | 176.90% |
| Operating Cash Flow: | 1,223.50 EUR | - |
| Cash and Cash Equivalents: | 912.40 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 21.26 | 24.25 |
| P/S Ratio: | 2.11 | 2.41 |
| P/BV ratio: | 3.11 | 3.55 |
| P/CF Ratio: | 9.38 | 10.70 |
| PEG: | 0.13 | 0.15 |
| Earnings Yield: | 4.70% | 4.12% |
| Dividend Yield: | 1.10% | 0.97% |
| Market Capitalization | ||
| Market Capitalization: | 12.57 bill. EUR | 13.1 bill. EUR |
| Free Float Market Cap.: | 7.64 bill. EUR | 8.72 bill. EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 190.79 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | 14.71% |
| Net Profit Margin: | 9.94% |
| Return on Equity: | 14.65% |
| Return on Assets: | 6.30% |
Financial Strength
| Liquidity I / Cash Ratio: | 53.78% |
| Liquidity II / Quick Ratio: | 109.70% |
| Liquidity III / Current Ratio: | 148.44% |
| Debt / Equity Ratio: | 132.38% |
| Dynam. Debt / Equity Ratio: | 399.28% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 12/31/2020 |
| Accounting Standard: | IFRS |
| Currency: | EUR |